lsting <-as_listing( out,key_cols =c("TRT01A", "CRTNPT", "AGSXRC", "AVISIT"),disp_cols =names(out),main_title ="Listing of Vital Signs: Safety-Evaluable Patients",main_footer ="Baseline is the patient's last observation prior to initiation of study drug. Abnormalities are flagged as high (H) or low (L) if outside the Roche standard reference range.")head(lsting, 20)
Listing of Vital Signs: Safety-Evaluable Patients
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Diastolic Blood
Pressure, Systolic Blood
Weight Sitting Diastolic Blood Pressure, Systolic Blood Respiratory Rate
Result Temperature Result Result Pressure, Sitting Pressure, Pulse Rate Result Result
Study (Kg); Weight (C); Temperature Rate (Pa); Sitting (Pa); Sitting (beats/min); Pulse Rate (breaths/min); Respiratory Rate
Treatment Center/Subject ID Age/Sex/Race Visit Day Range:(40-100) Change from BL Range:(36.1-37.2) Change from BL Range:(80-120) Change from BL Range:(120-180) Change from BL Range:(60-100) Change from BL Range:(12-20) Change from BL
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
A: Drug X BRA-1/105 38/M/BLACK OR AFRICAN AMERICAN WEEK 1 DAY 8 189 90.96 24.62 36.79 -1.88 101.10 -12.65 181.05/H 3.70 84.91 -2.05 18.34 1.13
WEEK 2 DAY 15 323 41.40 -24.93 36.52 -2.14 111.02 -2.72 132.47 -44.88 71.54 -15.42 9.81/L -7.40
WEEK 3 DAY 22 492 60.55 -5.78 35.03/L -3.64 88.35 -25.39 112.67/L -64.68 33.75/L -53.22 21.23/H 4.02
WEEK 4 DAY 29 550 69.69 3.36 35.71/L -2.95 100.74 -13.00 194.88/H 17.53 97.51 10.54 12.50 -4.71
WEEK 5 DAY 36 628 81.64 15.30 36.01/L -2.65 123.17/H 9.43 140.33 -37.02 62.50 -24.47 10.91/L -6.30
BRA-1/134 47/M/WHITE WEEK 1 DAY 8 203 42.95 -12.51 36.39 -1.38 112.71 26.38 148.69 -52.75 69.12 3.72 15.31 -2.84
WEEK 2 DAY 15 326 20.36/L -35.09 35.75/L -2.03 98.42 12.09 188.08/H -13.36 68.79 3.40 17.60 -0.55
WEEK 3 DAY 22 363 46.33 -9.12 35.43/L -2.34 97.88 11.55 160.05 -41.39 90.21 24.81 18.15 0.00
WEEK 4 DAY 29 367 43.83 -11.62 36.01/L -1.76 98.97 12.65 132.19 -69.25 88.39 23.00 19.62 1.48
WEEK 5 DAY 36 417 31.75/L -23.71 36.35 -1.42 124.26/H 37.94 134.30 -67.14 88.64 23.25 20.08/H 1.94
BRA-1/42 36/M/BLACK OR AFRICAN AMERICAN WEEK 1 DAY 8 265 115.27/H 8.42 37.35/H -1.67 107.32 5.90 173.89 27.40 66.14 26.13 9.23/L 7.13
WEEK 2 DAY 15 313 45.84 -61.01 36.01/L -3.01 110.97 9.55 144.75 -1.74 109.71/H 69.70 7.18/L 5.08
WEEK 3 DAY 22 325 85.70 -21.14 37.71/H -1.31 124.13/H 22.71 89.08/L -57.41 90.29 50.28 25.16/H 23.05
WEEK 4 DAY 29 535 44.64 -62.21 36.44 -2.58 79.51/L -21.91 140.78 -5.71 82.44 42.43 14.06 11.95
WEEK 5 DAY 36 729 85.21 -21.64 35.78/L -3.23 105.26 3.84 126.60 -19.89 88.71 48.70 25.98/H 23.87
BRA-1/93 34/F/ASIAN WEEK 1 DAY 8 402 47.51 -35.34 35.50/L -0.83 94.27 17.98 98.82/L -61.71 72.44 -7.85 14.97 0.22
WEEK 2 DAY 15 460 67.64 -15.21 37.96/H 1.62 109.98 33.69 104.21/L -56.32 104.70/H 24.41 14.90 0.16
WEEK 3 DAY 22 464 53.06 -29.78 36.33 -0.01 90.17 13.87 139.66 -20.87 111.13/H 30.85 22.86/H 8.12
WEEK 4 DAY 29 496 61.68 -21.17 33.52/L -2.82 112.76 36.47 128.82 -31.70 72.89 -7.39 20.77/H 6.03
WEEK 5 DAY 36 538 53.98 -28.86 35.71/L -0.63 80.20 3.91 137.16 -23.37 96.63 16.35 18.10 3.36
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Baseline is the patient's last observation prior to initiation of study drug. Abnormalities are flagged as high (H) or low (L) if outside the Roche standard reference range.
Experimental use!
WebR is a tool allowing you to run R code in the web browser. Modify the code below and click run to see the results. Altenatively, copy the code and click here to open WebR in a new tab.
Timestamp
Code
Sys.time()
[1] "2024-05-11 17:59:21 UTC"
Session Info
Code
sessionInfo()
R version 4.4.0 (2024-04-24)
Platform: x86_64-pc-linux-gnu
Running under: Ubuntu 22.04.4 LTS
Matrix products: default
BLAS: /usr/lib/x86_64-linux-gnu/openblas-pthread/libblas.so.3
LAPACK: /usr/lib/x86_64-linux-gnu/openblas-pthread/libopenblasp-r0.3.20.so; LAPACK version 3.10.0
locale:
[1] C
time zone: Etc/UTC
tzcode source: system (glibc)
attached base packages:
[1] stats graphics grDevices utils datasets methods base
other attached packages:
[1] rlistings_0.2.8 tibble_3.2.1 formatters_0.5.6 scda.2022_0.1.5
[5] scda_0.1.6 dplyr_1.1.4
loaded via a namespace (and not attached):
[1] vctrs_0.6.5 cli_3.6.2 knitr_1.46 rlang_1.1.3
[5] xfun_0.43 stringi_1.8.4 purrr_1.0.2 generics_0.1.3
[9] jsonlite_1.8.8 glue_1.7.0 backports_1.4.1 htmltools_0.5.8.1
[13] brio_1.1.5 fansi_1.0.6 rmarkdown_2.26 grid_4.4.0
[17] evaluate_0.23 fastmap_1.1.1 yaml_2.3.8 lifecycle_1.0.4
[21] compiler_4.4.0 codetools_0.2-20 htmlwidgets_1.6.4 testthat_3.2.1.1
[25] pkgconfig_2.0.3 tidyr_1.3.1 digest_0.6.35 R6_2.5.1
[29] tidyselect_1.2.1 utf8_1.2.4 pillar_1.9.0 magrittr_2.0.3
[33] checkmate_2.3.1 withr_3.0.0 tools_4.4.0
.lock file
Download the .lock file and use renv::restore() on it to recreate environment used to generate this website.